Medical Health & Life Science Research News

Explore North America's drug delivery market that will grow at a CAGR of 6.4% by 2024

Medical Market Research

North America Drug Delivery Market is expected to reach USD 823.55 billion by 2024 from USD 501.37 billion in 2016, at a CAGR of 6.4% in the forecast period 2017 to 2024.

North America Drug Delivery Market,By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical (Formulations, Transdermal Devices), Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Clinics, Home Healthcare, Community Centers, Others), By Distribution Channel (Direct Tenders, Hospital Pharmacies, Pharmacy Stores, Online Pharmacies), By Country (U.S., Canada, Mexico) – Trends and Forecast to 2024


Product Type {Oral [Solid, Liquid,Semi-Solid], Injectable [Devices (Conventional, Self-Injectable), Formulations], Topical [Transdermal Devices (Patches, Gels), Formulations], Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal]}, End-User [Hospitals, Clinics, Home Healthcare, Community Healthcare, Others], Distribution Channel [Hospital Pharmacy, Pharmacy Stores, Direct Tenders, Online Pharmacy], Country [United States, Canada and Mexico]


Some of the major factors driving the market forNorth America drug delivery market are rising prevalence of chronic disease such as diabetes, growth of biologics, new product launches, drug innovation, technological advancements and growth in the development of biologics.

Request for Report @…utm_campaign=Ravi

Rising Prevalence Of Chronic Disease Such As Diabetes

The prevalence of diseases and conditions such as cardiovascular diseases (CVDs), asthma, cancer, neurological disorders, stroke, diabetes, and respiratory diseases has increased significantly over a period of time.With the rising prevalence of chronic diseases, there is growing demand for the development and innovation of drug delivery systems such as pulmonary drug delivery, injectable drug delivery, and transdermal patches for targeted drug delivery.

Growth In The Development Of Biologics

Biologics is considered as one of the fastest growing segment in the pharmaceutical market. Development and manufacturing of biologics for both branded and generic drugs is becoming increasingly competitive with the presence of players.

Biologics are administered through injection such as Cimzia, Cosentyx, Enbrel, Humira, Simponi and Taltz are injected in the legs, abdomen or arms

Technological Development

With the development of new drug delivery systems administration of drugs through different routes becomes more efficient and effective. Implantable drug delivery system is also an example of technological advancement in the field of drug delivery market.Browse Full Report with Details


Some of the major players operating in this market are

  • Hoffmann-La Roche AG
  • Pfizer, Inc.
  • GlaxoSmithKline plc.
  • Merck & Co., Sanofi
  • Antares Pharma
  • 3M, Becton Dickinson and Company
  • Nemera, Cima Labs, Inc.
  • ali Medical Devices
  • Alkermes
  • Foamis
  • Ypsomed
  • Skyepharma AG
  • Valeant Pharmaceuticals DSM Biomedical
  • Catalent, Inc

Inquire report…utm_campaign=Ravi

News From

Data Bridge Market ResearchData Bridge Market Research
Category: Market Research Publishers and RetailersCompany about: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data bridge is an aftermath of sheer wi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.